Agios Pharmaceuticals, Inc. (AGIO)
28.00
+1.15
(+4.28%)
USD |
NASDAQ |
Dec 10, 16:00
27.73
-0.27
(-0.96%)
After-Hours: 05:18
Agios Pharmaceuticals EPS Diluted (Quarterly): -1.779 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | 0.6197 |
| Fulcrum Therapeutics, Inc. | -0.313 |
| Moderna, Inc. | -0.5128 |
| EyePoint Plc | -0.8513 |
| Vanda Pharmaceuticals, Inc. | -0.3822 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -103.43M |
| Revenue (Quarterly) | 12.88M |
| Total Expenses (Quarterly) | 116.31M |
| Enterprise Value | 724.44M |
| Gross Profit Margin (Quarterly) | 76.30% |
| Profit Margin (Quarterly) | -803.1% |
| Earnings Yield | -24.84% |
| Normalized Earnings Yield | -24.84 |